Dick E. de Vries
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
-
- T-cell and B-cell Immunology
- Biosimilars and Bioanalytical Methods
Papers in
-
- Systemic Lupus Erythematosus Research 2
- Rheumatoid Arthritis Research and Therapies 2
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Zhenhua Xu (4 shared papers)Yanli Zhuang (4 shared papers)Hugh M. Davis (4 shared papers)Honghui Zhou (4 shared papers)Adam Reich (2 shared papers)Annegret Kuhn (2 shared papers)Anna Woźniacka (2 shared papers)Jacek C. Szepietowski (2 shared papers)
- Journals
- Clinical Therapeutics (1 paper)Advances in Therapy (1 paper)The Journal of Clinical Pharmacology (1 paper)Journal of Investigative Dermatology (1 paper)International Journal of Clinical Pharmacology and Therapeutics (1 paper)
- Partner nations
- United StatesNetherlandsBelgium
In The Last Decade
Dick E. de Vries
7 papers receiving 314 citations
Peers
Comparison fields: 5 of 48
- Rheumatology 178
- Immunology 158
- Pharmacology 39
- Radiology, Nuclear Medicine and Imaging 101
- Hematology 45
Countries citing papers authored by Dick E. de Vries
This map shows the geographic impact of Dick E. de Vries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dick E. de Vries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dick E. de Vries more than expected).
Fields of papers citing papers by Dick E. de Vries
This network shows the impact of papers produced by Dick E. de Vries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dick E. de Vries. The network helps show where Dick E. de Vries may publish in the future.
Co-authors
The 25 scholars most cited alongside Dick E. de Vries, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 94 | |
| 2 | 2011 | 67 | |
| 3 | 2015 | 63 | |
| 4 | 2011 | 38 | |
| 5 | 2022 | 29 | |
| 6 | 2013 | 20 | |
| 7 | 2017 | 8 |
About Dick E. de Vries
Dick E. de Vries is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging, Immunology, Genetics and Oncology, having authored 7 papers that have together received 319 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), Systemic Lupus Erythematosus Research (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (1 paper) and Inflammatory Bowel Disease (1 paper). The work is most often cited by research in Rheumatology (178 citations), Immunology (158 citations), Pharmacology (39 citations), Radiology, Nuclear Medicine and Imaging (101 citations) and Hematology (45 citations). Dick E. de Vries has collaborated with scholars based in United States, Netherlands and Belgium. Frequent co-authors include Zhenhua Xu, Yanli Zhuang, Hugh M. Davis, Honghui Zhou, Adam Reich, Annegret Kuhn, Anna Woźniacka, Jacek C. Szepietowski, Filippa Nyberg and Francisco León. Their work appears in journals such as Clinical Therapeutics, Advances in Therapy, The Journal of Clinical Pharmacology, Journal of Investigative Dermatology and International Journal of Clinical Pharmacology and Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.